{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:05:23Z","timestamp":1792674323583,"version":"4.5.0"},"reference-count":136,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Progressive multiple sclerosis (MS) is characterized by insidious clinical worsening that is difficult to accurately quantify and predict. Biofluid markers and electrophysiological measures are potential candidate outcome measures in clinical trials, allowing the quantification of nervous damage occurring in the disease. Neurofilaments are highly specific neuronal proteins. They may have come closest to such applications by their higher concentrations repeatedly demonstrated in cerebrospinal fluid (CSF) in all stages of MS, during relapses, their responsiveness to disease-modifying treatments in relapsing and progressive MS and their associations with measures of inflammatory and degenerative magnetic resonance imaging (MRI) outcomes. Digital single-molecule array (Simoa) technology improves accuracy of bioassays in the quantification of neurofilament light chain (NfL) in serum and plasma. NfL seems to mark a common final path of neuroaxonal injury independent of specific causal pathways. CSF and blood levels of NfL are highly correlated across various diseases including MS, suggesting that blood measurements may be useful in assessing response to treatment and predicting future disease activity. Other biomarkers like matrix metalloproteinases, chemokines, or neurotrophic factors have not been studied to a similar extent. Such measures, especially in blood, need further validation to enter the trial arena or clinical practice. The broadening armamentarium of highly sensitive assay technologies in the future may shed even more light on patient heterogeneity and mechanisms leading to disability in MS. Evoked potentials (EPs) are used in clinical practice to measure central conduction of central sensorimotor pathways. They correlate with and predict the severity of clinical involvement of their corresponding function. Their validation for use in multicenter studies is still lacking, with the exception of visual EPs. If further validated, EPs and fluid biomarkers would represent useful outcome measures for clinical trials, being related to specific mechanisms of the ongoing pathologic changes.<\/jats:p>","DOI":"10.1177\/1352458517732844","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T04:00:49Z","timestamp":1508299249000},"page":"1600-1613","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["Fluid biomarker and electrophysiological outcome measures for progressive MS trials"],"prefix":"10.1177","volume":"23","author":[{"given":"Christian","family":"Barro","sequence":"first","affiliation":[{"name":"Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Experimental Neurology (INSPE), San Raffaele Hospital, Milan, Italy\/Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[{"name":"Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland\/Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Experimental Neurology (INSPE), San Raffaele Hospital, Milan, Italy\/Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Kappos","sequence":"additional","affiliation":[{"name":"Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380502"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.514"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-07-02195.2001"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a0fe3f"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512458010"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513482374"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077163"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13274"},{"key":"e_1_3_3_11_2","first-page":"126","article-title":"Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome","volume":"87","author":"Disanto G","year":"2015","unstructured":"Disanto G, Adiutori R, Dobson R, . Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2015; 87: 126\u2013129.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.402"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000098880.19793.B6"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22247"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512466929"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12151"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13881"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515623365"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24954"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517715132."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142988.49341.D1"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513490544"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7507-4"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(03)03219-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12579"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.08.004"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2007.0488"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.06.008"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001491"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516639384"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002832"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003653"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000361"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12239"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003085"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13162"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509359725"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1641"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/2211068215589580"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.11.036"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-1195"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.290"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.6117"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.017236"},{"key":"e_1_3_3_46_2","first-page":"217802","article-title":"The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies","volume":"2012","author":"Petzold A","year":"2012","unstructured":"Petzold A, Plant GT. The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies. Mult Scler Int 2012; 2012: 217802.","journal-title":"Mult Scler Int"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22169"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070019"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306789"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70233-3"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805065105"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00794.x"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.60.1.52"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1191\/135248506ms1274oa"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(03)00006-7"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.6.1626"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms880sr"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1402"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(01)00101-1"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000361"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(92)90192-N"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458505ms1193oa"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400606"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400607"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh680"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512473362"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c5b457"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510389102"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011986"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509107017"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00152-R"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf165"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5863-2"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e2414b"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023489"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.02.012"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00319-3"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.05.057"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2017.03.002"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514549397"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv017"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq035"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514561906"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.01.013"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062960"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10606"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.06.007"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510382247"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.09.004"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.04.024"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02532.x"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513503052"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(03)00098-4"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245850100700108"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.4.655"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511398887"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2005.01649.x"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514528765"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.05.018"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312972"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24552"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001642"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.325"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.086280"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00028-5"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.11.2162"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.07.009"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513490543"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517707265"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0608-1"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514524293"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30377-5"},{"key":"e_1_3_3_113_2","volume-title":"68th meeting of the American academy of neurology","author":"Green A","unstructured":"Green A, Gelfand J, Cree B, . Positive phase II double-blind randomized placebo-controlled crossover trial of clemastine. In: 68th meeting of the American academy of neurology, Vancouver, BC, Canada, 15\u201321 April 2016."},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511415452"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70305-2"},{"key":"e_1_3_3_116_2","article-title":"No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in multiple sclerosis","author":"Pisa M","unstructured":"Pisa M, Guerrieri S, Di Maggio G, . No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in multiple sclerosis. Neurology, in press.","journal-title":"Neurology"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-007-9112-7"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-007-9072-y"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-014-9467-5"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7434"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-008-9147-4"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2015.03.012"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513506955"},{"key":"e_1_3_3_124_2","first-page":"13","article-title":"Evoked potentials in diagnosis and monitoring of multiple sclerosis","volume":"49","author":"Comi G","year":"1999","unstructured":"Comi G, Leocani L, Medaglini S, . Evoked potentials in diagnosis and monitoring of multiple sclerosis. Electroencephalogr Clin Neurophysiol Suppl 1999; 49: 13\u201318.","journal-title":"Electroencephalogr Clin Neurophysiol Suppl"},{"key":"e_1_3_3_125_2","first-page":"257","article-title":"Cortical excitability changes over time in progressive multiple sclerosis","volume":"30","author":"Ayache SS","year":"2015","unstructured":"Ayache SS, Creange A, Farhat WH, . Cortical excitability changes over time in progressive multiple sclerosis. Funct Neurol 2015; 30: 257\u2013263.","journal-title":"Funct Neurol"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.1.31"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306860"},{"issue":"14","key":"e_1_3_3_128_2","article-title":"Loss of lower limb Motor Evoked Potentials (MEP) as a sign of Primary Progressive Multiple Sclerosis (PPMS) progression","volume":"84","author":"Paine R","year":"2015","unstructured":"Paine R, Bielekova B, Lehky T. Loss of lower limb Motor Evoked Potentials (MEP) as a sign of Primary Progressive Multiple Sclerosis (PPMS) progression. Neurology 2015; 84(14): P5.204.","journal-title":"Neurology"},{"key":"e_1_3_3_129_2","volume-title":"7th joint ECTRIMS\u2013ACTRIMS meeting","author":"Guerrieri S","unstructured":"Guerrieri S, Di Maggio G, Pisa M, . Visual pathway involvement in progressive multiple sclerosis: Demyelination and neurodegeneration are higher in secondary progressive than primary progressive patients. In: 7th joint ECTRIMS\u2013ACTRIMS meeting, Paris, 25\u201328 October 2017."},{"key":"e_1_3_3_130_2","volume-title":"7th joint ECTRIMS\u2013ACTRIMS meeting","author":"Pisa M","unstructured":"Pisa M, Gelibter S, Fichera M, . Upper limb motor evoked potentials as a motor outcome in progressive MS. In: 7th joint ECTRIMS\u2013ACTRIMS meeting, Paris, 25\u201328 October 2017."},{"key":"e_1_3_3_131_2","first-page":"819","article-title":"Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures","volume":"52","author":"Nociti V","year":"2016","unstructured":"Nociti V, Prosperini L, Ulivelli M, . Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures. Eur J Phys Rehabil Med 2016; 52: 819\u2013826.","journal-title":"Eur J Phys Rehabil Med"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513512541"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0728-9"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.06.025"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2016.12.030"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.10.006"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062523"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458517732844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458517732844","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458517732844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:52:15Z","timestamp":1777693935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458517732844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":136,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1177\/1352458517732844"],"URL":"https:\/\/doi.org\/10.1177\/1352458517732844","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}